drugset / Trial / NCT01785147

Efficacy and Safety of BP1.4979 in Smoking Cessation

NCT01785147 ↗

Phase 2 Completed 219 enrolled Bioprojet
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical study which aim is to assess in heavy smokers willing to quit smoking the efficacy and the safety profile of BP1.4979 for smoking cessation on the total abstinence measured by subject diary and confirmed by exhaled CO (abstinent \< 10 ppm).

Timeline

Start
2013-02
Primary completion
2014-07
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BP1.4979 Small molecule 3 mg —
Subject BP1.4979 Small molecule 10 mg —
Subject BP1.4979 Small molecule 15 mg —

Indications